Bruker (BRKR) EBT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bruker (BRKR) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | -211.00 |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 1,575.00 |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 3,000.00 |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | -138.00 |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | -730.00 |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 30,357.00 |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | -871.00 |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | -1,462.00 |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 2,904.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,462.00 |
| Mar 31, 2026 | -944.00 |
| Dec 31, 2025 | 2,055.00 |
| Sep 30, 2025 | -2,858.00 |
| Jun 30, 2025 | -773.00 |
| Mar 31, 2025 | -830.00 |
| Dec 31, 2024 | 1,153.00 |
| Sep 30, 2024 | -1,147.00 |
| Jun 30, 2024 | 930.00 |
| Mar 31, 2024 | 317.00 |
| Dec 31, 2023 | 639.00 |
| Sep 30, 2023 | 132.00 |
| Jun 30, 2023 | 116.00 |
| Mar 31, 2023 | 812.00 |
| Dec 31, 2022 | 42.00 |
| Sep 30, 2022 | 427.00 |
| Jun 30, 2022 | 1,609.00 |
| Mar 31, 2022 | 1,713.00 |
| Dec 31, 2021 | -114.00 |
| Sep 30, 2021 | 385.00 |